(Total Views: 156)
Posted On: 01/24/2023 12:05:45 PM
Post# of 78

$DYAI News Article - Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate https://marketwirenews.com/news-releases/dyad...90664.html


My Twitter: WhyteStocks